Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lizza E. L. Hendriks, Esther G. C. Troost, Allan Steward, Gerben P. Bootsma, Katrien De Jaeger, Ben E. E. M. van den Borne & Anne-Marie C. Dingemans. (2014) Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases. Acta Oncologica 53:7, pages 945-951.
Read now
Read now
Katarzyna Komosinska, Lucyna Kepka, Anna Niwinska, Lucyna Pietrzak, Marek Wierzchowski, Dobromira Tyc-Szczepaniak, Agnieszka Kaczmarczyk & Krzysztof Bujko. (2010) Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status. Acta Oncologica 49:3, pages 382-388.
Read now
Read now
Carsten Nieder, Kirsten Marienhagen, Hans Geinitz & Michael Molls. (2009) Validation of the graded prognostic assessment index for patients with brain metastases. Acta Oncologica 48:3, pages 457-459.
Read now
Read now
Articles from other publishers (39)
Andrew Lian, Colton Ladbury & Arya Amini. (2022) Stereotactic Radiosurgery in a Small Cell Lung Cancer Patient With Numerous Brain Metastases. Cureus.
Crossref
Crossref
Ullas Batra, Kundan Singh Chufal, Shrinidhi Nathany, Irfan Ahmad, Rahul Lal Chowdhary, Mansi Sharma, Praveen Jain & Munish Gairola. (2022) Immunotherapy in advanced non-small-cell lung cancer (NSCLC) after progression on chemotherapy: real-world results from a prospective institutional cohort. Immunotherapy 14:11, pages 851-858.
Crossref
Crossref
Shivansh Mishra, Mohamed Abbas, Kanak Jindal, Jyotindra Narayan & Santosha K. Dwivedy. 2022. Revolutions in Product Design for Healthcare. Revolutions in Product Design for Healthcare
207
227
.
Hongwei Li, Ruiqi Xue, Xiaotang Yang, Songye Han, Weihua Yang, Xin Song, Xiaqin Zhang, Jianzhong Cao, Sufang Jia, Weili Wang & Jianhong Lian. (2021) Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Wen Ouyang, Jing Yu, Yan Zhou, Jing Hu, Zhao huang, Junhong Zhang & Conghua Xie. (2020) Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer. BMC Cancer 20:1.
Crossref
Crossref
Rui Huang, Johannes Boltze & Shen Li. (2020) Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review. Frontiers in Oncology 10.
Crossref
Crossref
Hiromasa Kobayashi, Makoto Hamasaki, Takashi Morishita, Masayo Yoshimura, Masani Nonaka, Hiroshi Abe, Tooru Inoue & Kazuki Nabeshima. (2018) Clinicopathological and genetic characteristics associated with brain metastases from lung adenocarcinoma and utility as prognostic factors. Oncology Letters.
Crossref
Crossref
Jorge Ávila. (2018) Supervivencia en pacientes con metástasis cerebrales tratados con radioterapia holocraneal. Revista Colombiana de Cancerología 22:3, pages 99-104.
Crossref
Crossref
Elie El Rassy, Angela Botticella, Joseph Kattan, Cecile Le Péchoux, Benjamin Besse & Lizza Hendriks. (2018) Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment. Cancer Treatment Reviews 68, pages 69-79.
Crossref
Crossref
Zoltan Lohinai, Thomas Klikovits, Judit Moldvay, Gyula Ostoros, Erzsebet Raso, Jozsef Timar, Katalin Fabian, Ilona Kovalszky, István Kenessey, Clemens Aigner, Ferenc Renyi-Vamos, Walter Klepetko, Balazs Dome & Balazs Hegedus. (2017) KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis. Scientific Reports 7:1.
Crossref
Crossref
Lizza E.L. Hendriks, -->Anita J.W.M. Brouns, Mohammad Amini, Wilma Uyterlinde, Robin Wijsman, Jan Bussink, Bonne Biesma, S. Bing Oei, Jos -->A. Stigt, Gerben P. Bootsma, José S.A. Belderbos, Dirk K.M. De Ruysscher, Michel M. Van den Heuvel & Anne-Marie C. Dingemans. (2016) Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?. Lung Cancer 101, pages 68-75.
Crossref
Crossref
Hongwei Li, Xiaqin Zhang, Jianzhong Cao, Pengcheng Su, Jianhong Lian, Xing Song, Weihua Yang, Songyan Han, Yanfeng Xi & Yaohua Wang. (2015) Exon 19 deletion of epidermal growth factor receptor is associated with prolonged survival in brain metastases from non-small-cell lung cancer. Tumor Biology 36:12, pages 9251-9258.
Crossref
Crossref
Bo Li, Suo-zhu Sun, Ming Yang, Jian-ling Shi, Wei Xu, Xi-fan Wang, Mao-min Song & Huo-ming Chen. (2015) The correlation between EGFR mutation status and the risk of brain metastasis in patients with lung adenocarcinoma. Journal of Neuro-Oncology 124:1, pages 79-85.
Crossref
Crossref
Yong Kyun WonJa Young LeeYoung Nam KangJi Sun JangJin-Hyoung KangSo-Lyoung JungSoo Yoon SungIn Young JoHee Hyun ParkDong-Soo LeeJi Hyun ChangYun Hee LeeYeon-Sil Kim. (2015) Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer. Radiation Oncology Journal 33:3, pages 207.
Crossref
Crossref
Zhenfei Xiang, Jun Chen, Huanle Zhang, Li Shen & Qichun Wei. (2015) Whole Brain Radiotherapy-Based Combined Modality Treatment of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis of Prognostic Factors. Oncology Research and Treatment 38:1-2, pages 35-40.
Crossref
Crossref
Zhe Ji, Nan Bi, Jingbo Wang, Zhouguang Hui, Zefen Xiao, Qinfu Feng, Zongmei Zhou, Dongfu Chen, Jima Lv, Jun Liang, Chengcheng Fan, Lipin Liu & Luhua Wang. (2014) Risk Factors for Brain Metastases in Locally Advanced Non-Small Cell Lung Cancer With Definitive Chest Radiation. International Journal of Radiation Oncology*Biology*Physics 89:2, pages 330-337.
Crossref
Crossref
James W SniderIIIIII, Vinai Gondi, Paul D Brown, Wolfgang Tome & Minesh P Mehta. (2014) Prophylactic cranial irradiation: recent outcomes and innovations. CNS Oncology 3:3, pages 219-230.
Crossref
Crossref
L.E.L. Hendriks, E.F. Smit, B.A.H. Vosse, W.W. Mellema, D.A.M. Heideman, G.P. Bootsma, M. Westenend, C. Pitz, G.J. de Vries, R. Houben, K. Grünberg, M. Bendek, E.-J.M. Speel & A.-M.C. Dingemans. (2014) EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?. Lung Cancer 84:1, pages 86-91.
Crossref
Crossref
TETSUYA KOMATSU, ETSUO KUNIEDA, YUKIO OIZUMI, YOSHIFUMI TAMAI & TAKESHI AKIBA. (2013) Clinical characteristics of brain metastases from lung cancer according to histological type: Pretreatment evaluation and survival following whole-brain radiotherapy. Molecular and Clinical Oncology 1:4, pages 692-698.
Crossref
Crossref
Tomohiko Matsuyama, Kasei Kogo & Natsuo Oya. (2013) Clinical Outcomes of Biological Effective Dose-Based Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors From Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 85:4, pages 984-990.
Crossref
Crossref
Hsin-Lun Lee, Tao-Sang Chung, Lai-Lei Ting, Jo-Ting Tsai, Shang-Wen Chen, Jeng-Fong Chiou, Henry Wing-Cheung Leung & H Eugene Liu. (2012) EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases. Radiation Oncology 7:1.
Crossref
Crossref
Kan Wu, Bing Xia & Shenglin Ma. (2012) Advance of prophylactic cranial irradiation in lung cancer. The Chinese-German Journal of Clinical Oncology 11:10, pages 559-565.
Crossref
Crossref
Anna Niwińska & Magdalena Murawska. (2012) New Breast Cancer Recursive Partitioning Analysis Prognostic Index in Patients With Newly Diagnosed Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 82:5, pages 2065-2071.
Crossref
Crossref
M. Buglione, L. Bandera, S. Grisanti, N. Pasinetti, P. Borghetti, F. Barbera, L. Triggiani, L. Costa, B. Shehi, B. Bonetti & S. Magrini. (2011) The impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patientsImpatto dell’istologia e della classificazione RPA nel predire la prognosi di pazienti affetti da metastasi cerebrali e trattati con radioterapia ipofrazionata sull’encefalo in toto: analisi di 382 pazienti. La radiologia medica 117:1, pages 133-147.
Crossref
Crossref
Waldo Ortuzar, Nasser Hanna, Eduardo Pennella, Guangbin Peng, Corey Langer, Matthew Monberg & Giorgio Scagliotti. (2012) Brain Metastases as the Primary Site of Relapse in Two Randomized Phase III Pemetrexed Trials in Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer 13:1, pages 24-30.
Crossref
Crossref
Lucyna Kepka & Milena Kolodziejczyk. 2012. Tumors of the Central Nervous System, Volume 4. Tumors of the Central Nervous System, Volume 4
273
279
.
F. Barlesi, R. Gervais, H. Lena, J. Hureaux, H. Berard, D. Paillotin, S. Bota, I. Monnet, A. Chajara & G. Robinet. (2011) Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01). Annals of Oncology 22:11, pages 2466-2470.
Crossref
Crossref
Cai-xing Sun, Tao Li, Xiao Zheng, Ju-fen Cai, Xu-li Meng, Hong-jian Yang & Zheng Wang. (2011) Recursive partitioning analysis classification and graded prognostic assessment for non-small cell lung cancer patients with brain metastasis: A retrospective cohort study. Chinese Journal of Cancer Research 23:3, pages 177-182.
Crossref
Crossref
A. Paumier, X. Cuenca & C. Le Péchoux. (2011) Prophylactic cranial irradiation in lung cancer. Cancer Treatment Reviews 37:4, pages 261-265.
Crossref
Crossref
Milena Niemiec, Maciej Głogowski, Dobromira Tyc-Szczepaniak, Marek Wierzchowski & Lucyna Kępka. (2011) Characteristics of long-term survivors of brain metastases from lung cancer. Reports of Practical Oncology & Radiotherapy 16:2, pages 49-53.
Crossref
Crossref
Alexander Chi & Ritsuko Komaki. (2010) Treatment of Brain Metastasis from Lung Cancer. Cancers 2:4, pages 2100-2137.
Crossref
Crossref
J.P. Agarwal, T. Wadasadawala, A. Munshi, P. Chadda, R. Apsani, M. Upasani, S.G. Laskar, C.S. Pramesh, G. Karimundackal, H. Menon, K. Prabhash & N. Jambhekar. (2010) Validation of Recursive Partitioning Analysis Classification in Patients with Brain Metastases from Non-small Cell Lung Cancer Treated with Short-course Accelerated Radiotherapy. Clinical Oncology 22:10, pages 837-843.
Crossref
Crossref
P Sundaresan, R Yeghiaian‐Alvandi & V Gebski. (2010) Prognostic index to identify patients who may not benefit from whole brain radiotherapy for multiple brain metastases from lung cancer. Journal of Medical Imaging and Radiation Oncology 54:1, pages 69-75.
Crossref
Crossref
Carsten Nieder & Minesh P Mehta. (2009) Prognostic indices for brain metastases – usefulness and challenges. Radiation Oncology 4:1.
Crossref
Crossref
Gregory M.M. Videtic, Chandana A. Reddy, Samuel T. Chao, Thomas W. Rice, David J. Adelstein, Gene H. Barnett, Tarek M. Mekhail, Michael A. Vogelbaum & John H. Suh. (2009) Gender, Race, and Survival: A Study in Non–Small-Cell Lung Cancer Brain Metastases Patients Utilizing the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification. International Journal of Radiation Oncology*Biology*Physics 75:4, pages 1141-1147.
Crossref
Crossref
Carsten Nieder, Reinhard Thamm, Sabrina T. Astner & Michael Molls. (2008) Disease Presentation and Treatment Outcome in Very Young Patients with Brain Metastases from Lung Cancer. Onkologie 31:6, pages 305-308.
Crossref
Crossref
Chien-Hung Gow, Chun-Ru Chien, Yih-Leong Chang, Yueh-Hsia Chiu, Sung-Hsin Kuo, Jin-Yuan Shih, Yeun-Chung Chang, Chong-Jen Yu, Chih-Hsin Yang & Pan-Chyr Yang. (2008) Radiotherapy in Lung Adenocarcinoma with Brain Metastases: Effects of Activating Epidermal Growth Factor Receptor Mutations on Clinical Response. Clinical Cancer Research 14:1, pages 162-168.
Crossref
Crossref
Sunil Krishnan, Vishal Rana, Nora A. Janjan, James L. Abbruzzese, Morris S. Gould, Prajnan Das, Marc E. Delclos, Shana Palla, Sushovan Guha, Gauri Varadhachary, Douglas B. Evans, Robert A. Wolff & Christopher H. Crane. (2006) Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107:11, pages 2589-2596.
Crossref
Crossref
Hülya Gülbaş, Haldun Şükrü Erkal & Meltem Serin. (2006) The Use of Recursive Partitioning Analysis Grouping in Patients with Brain Metastases from Non-Small-Cell Lung Cancer. Japanese Journal of Clinical Oncology 36:4, pages 193-196.
Crossref
Crossref